Open access · CC-BY
via OpenAlex
Multidimensional effects of metformin in patients with type 2 diabetes
Lyudmila Alexandrovna Ruyatkina, D. S. Ruyatkin
Diabetes Mellitus · 2016 · ▲ 12 citations
Abstract
In modern algorithms for the treatment of type 2 diabetes, metformin is positioned as a first-line drug, which, when the disease progresses, is universally combined with other groups of hypoglycemic drugs, including insulin. Review of literature demonstrates the multifaceted effects of metformin with its efficacy and extensive safety range, allowing the drug to be used not only for glycemic control but also for the management of cardiovascular risk factors. Here we present a retrospective study of whether cardiovascular safety of hypoglycemic drugs should be assessed, on the basis of which the idea of a vulnerable patient in the presence of diabetes can be formulated, and the necessity of joint management of such patients by an endocrinologist and cardiologist can be postulated. The mechanisms of macrovascular protection by the drug demonstrated in the UKPDS with the phenomenon of metabolic memory are analysed along with a discussion regarding their lipid-lowering and antisclerotic effects using modern analytical reviews. The features of the action of long form of the drug (Glucophage Long) are considered. The pleiotropic possibilities of metformin, the expansion of the present indications and the prospects of application as well as new hypotheses about its mechanism of action are discussed. The possible effects of the drug on the components of the gastrointestinal tractbrainliver axis are discussed, and the effects of metformin on homeostasis due to the effect on the microbiota are presented.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.14341/dm2003458-64
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Ruyatkina, L.A., & Ruyatkin, D.S. (2016). Multidimensional effects of metformin in patients with type 2 diabetes. <em>Diabetes Mellitus</em>. https://doi.org/10.14341/dm2003458-64
Vancouver
Ruyatkina LA, Ruyatkin DS. Multidimensional effects of metformin in patients with type 2 diabetes. Diabetes Mellitus. 2016. doi:10.14341/dm2003458-64.
BibTeX
@article{lyudmila2016Multid,
title = {Multidimensional effects of metformin in patients with type 2 diabetes},
author = {Lyudmila Alexandrovna Ruyatkina and D. S. Ruyatkin},
journal = {Diabetes Mellitus},
year = {2016},
doi = {10.14341/dm2003458-64},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Physiology 2021
Open access · CC-BY
Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
Biochemical Journal 2015
Preprint · CC-BY
Repurposing metformin: an old drug with new tricks in its binding pockets
IntechOpen eBooks 2020
Open access · CC-BY
New Insight into Metformin Mechanism of Action and Clinical Application
Vascular Health and Risk Management 2024
Open access · CC-BY
Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights
Endokrynologia Polska 2017
Open access · CC-BY
Metformin — a new old drug
The Science Journal of the Lander College of Arts and Sciences 2021
Preprint · OA